News

13
Sep

Genoskin kicks off fundraising campaign

Genoskin kicks off fundraising campaign at CCI FINDays The Genoskin team is now officially ready to launch its biggest fundraising campaign so far, which aims to finance our international expansion. Pascal Descargues, our CEO, is heading for Paris next week to attend the CCI FINDays, the first in a series of fundraising meetings. CCI FINDays is a French event designed to help small and start-up
Read more
29
Aug

PRESS RELEASE – Genoskin brings unique alternative to animal testing to the US

Skin biotech to set up Boston production unit that recycles excess human skin Toulouse, France, August 29, 2017 – Genoskin, a company that provides a cutting-edge alternative to animal testing by keeping donated human skin alive, today announces its expansion into North America. The biotech has established a representative office in Boston and plans to open a local production unit
Read more
12
Jul

Genoskin to attend ESDR 2017

GENOSKIN TO ATTEND 47TH ANNUAL ESDR MEETING 2017 Here at Genoskin, we’re pleased to announce our presence at the 47th Annual Meeting of the European Society for Dermatological Research (ESDR). The meeting will take place in Salzburg, Austria from September 27th to 30th, 2017. The ESDR aims to promote research in dermatology and skin biology and open up the dialogue between

Read more

9
May

Genoskin launches HistoSkin® FFPE skin tissue blocks

HistoSkin® FFPE skin tissue blocks In order to help our customers conduct the skin research they need, Genoskin launches HistoSkin® to simplify access to FFPE human skin tissue blocks and sections for studies and analysis. HistoSkin® offers a wide range of fully characterized FFPE tissue blocks and sections and provides new research opportunities involving human skin. A wide selection of donors Every year, Genoskin collects a wide range

Read more

2
May

Boston-Paris Biotechnology Summit

Genoskin to attend Boston-Paris Biotechnology Summit In order to better serve our American customers, Genoskin plans to set up a production unit in Boston in 2018. Our project has recently been selected by the NETVA program, which helps companies  prepare for this strategic move. In May, we will attend the Boston-Paris Biotechnology Summit, an independent conference supported by a panel of biotech professionals from both sides of the

Read more

25
Apr

Genoskin invited to MEDEF meeting on how CEOs can drive change

Every year, the MEDEF, France’s largest entrepreneurial organisation, sets up local conferences in an attempt to bring companies together under a predefined theme. This year, Genoskin was invited to the 7th Edition of the Entrepreneurial Event (Grande Tribune des Entrepreneurs) to contribute to the discussion on the role of CEOs in driving change. The widely attended conference was headed by Pierre Gataz, the MEDEF’s president (see

Read more